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Abstract
Background: Bone marrow mesenchymal stem cells (MSCs) have shown positive therapeutic effects for meniscus
regeneration and repair. Preliminary in vitro work has indicated positive results for MSC applications for meniscus
tissue engineering; however, more information is needed on how to direct MSC behavior. The objective of this
study was to examine the effect of MSC co-culture with primary meniscal fibrochondrocytes (FCCs) in a three-
dimensional collagen scaffold in fibrochondrogenic media. Co-culture of MSCs and FCCs was hypothesized to
facilitate the transition of MSCs to a FCC cell phenotype as measured by matrix secretion and morphology.
Methods: MSCs and FCCs were isolated from bovine bone marrow and meniscus, respectively. Cells were seeded
in a 20 mg/mL high-density type I collagen gel at MSC:FCC ratios of 0:100, 25:75, 50:50, 75:25, and 100:0. Constructs
were cultured for up to 2 weeks and then analyzed for cell morphology, glycosaminoglycan content, collagen
content, and production of collagen type I, II, and X.
Results: Cells were homogeneously mixed throughout the scaffold and cells had limited direct cell–cell contact.
After 2 weeks in culture, MSCs transitioned from a spindle-like morphology toward a rounded phenotype, while
FCCs remained rounded throughout culture. Although MSC shape changed with culture, the overall size was
significantly larger than FCCs throughout culture. While 75:25 and 100:0 (MSC mono-culture) culture groups
produced significantly more glycosaminoglycan (GAG)/DNA than FCCs in mono-culture, GAG retention was highest
in 50:50 co-cultures. Similarly, the aggregate modulus was highest in 100:0 and 50:50 co-cultures. All samples
contained both collagen types I and II after 2 weeks, and collagen type X expression was evident only in MSC
mono-culture gels.
Conclusions: MSCs shift to a FCC morphology in both mono- and co-culture. Co-culture reduced hypertrophy by
MSCs, indicated by collagen type X. This study shows that MSC phenotype can be influenced by indirect
homogeneous cell culture in a three-dimensional gel, demonstrating the applicability of MSCs in meniscus tissue
engineering applications.
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Background
Meniscus damage is one of the most common knee in-
juries with a reported incidence of 61/100,000 and over
1 million procedures performed annually in the United
States [1]. Like most cartilaginous structures, the menis-
cus has a limited healing capacity because the tissue is
primarily avascular. Depending on the severity of the
tear, the meniscus is either partially resected or replaced
using a meniscus allograft. Meniscal allograft procedures
are limited in availability, shape and immunocompatibil-
ity [2–4]. Recent studies have demonstrated the applic-
ability of intra-articular stem cell injection for repair of
small meniscal tears [5–8]. For more extensive injuries,
tissue engineering of the meniscus may offer a promising
alternative to meniscus allograft replacement.
Progress toward a tissue-engineered meniscus has
shown great promise, but has yet to reach clinical appli-
cation [9–13]. Tissue-engineered menisci often lack na-
tive biochemical and mechanical properties necessary
for successful function in vivo. The addition of cells to
engineered menisci provides an essential mediator for
development and modification of the construct, often
resulting in a better match to native properties. Previ-
ously, we have shown that fibrochondrocytes (FCCs)
seeded in a collagen tissue-engineered meniscus under
static mechanical boundary conditions are able to mimic
anisotropic fiber formation seen in native menisci as well
as improve mechanical properties [14]. However, obtain-
ing the sufficient number of cells for an engineered me-
niscus is challenging. FCCs derived from surgical debris
have been shown as a viable cell source for tissue engin-
eering [15], but they remain a challenge since cell num-
ber is limited, as FCCs proliferate slowly and often lose
their phenotype in two-dimensional (2D) culture [16].
As tissue engineered constructs approach clinical appli-
cation there is an increasing need for a cell source that
is easy to obtain and expand in culture.
Mesenchymal stem cells (MSCs) have shown great po-
tential as a treatment option for meniscus repair and re-
generation. Intra-articular injection of bone marrow-
derived MSCs in human and animal studies have dem-
onstrated that MSCs mobilize to the site of injury and
contribute to tissue regeneration [5–8]. MSCs from the
bone marrow are easily obtained and expanded in cul-
ture and are well established as multipotent stem cells
that can differentiate down chondrogenic lineage [17,
18]. However, differentiation of MSCs down the fibro-
chondrogenic lineage is not well understood [19]. MSC
co-culture with either meniscus or articular cartilage
cells has been shown to direct differentiation and in-
crease matrix secretion [20–24]. Pellet culture of MSCs
co-cultured with meniscus FCCs increased expression of
fibrochondrogenic genes, reduced hypertrophy, and in-
creased matrix production [20, 21]. However, studies
using FCC co-culture with stem cells have been limited
to 2D culture and three-dimensional (3D) cell pellets.
Little is known about how cell proximity, exogenous sig-
naling, and cell–matrix interactions will affect cellular
phenotype in 3D scaffold culture.
The goal of this study was to evaluate the effects of 3D
co-culture of MSCs and FCCs on cell phenotype indi-
cated by cell shape, matrix secretion, and mechanical
properties of constructs. We hypothesize that co-culture
of MSCs with FCCs in a 3D collagen scaffold will fa-




Methods for cell isolation were based on those previ-
ously described, in which all cells were isolated from 1-
to 3-day-old bovids postmortem [25, 26]. Briefly, MSCs
were extracted by washing the trabecular region of the
femoral head with heparin supplemented media [26].
The extract solution was centrifuged at 300 × g and the
pellet was suspended and plated on tissue culture plastic.
Plates were washed after 48 hours to remove the un-
attached cell population. Trilineage differentiation assays
were performed to confirm multipotency of MSCs for
ostegenicity, adipogenicity, and chondrogenicity (Additional
file 1) [18, 27]. MSCs were plated at 2000 cells/cm2 and
expanded in 2D culture until passage 4 with a growth
medium containing low glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10 % fetal
bovine serum (FBS), 100 IU/mL penicillin, 100 μg/mL
streptomycin, 0.25 μg/mL amphotericin B, 2 mM L-
glutamine, and 1 ng/mL basic fibroblast growth factor.
FCCs were digested from menisci in 0.3 % collagenase
(Worthington Biochemical Corporation, Lakewood,
NJ, USA) in DMEM with 100 μg/mL penicillin and
100 μg/mL streptomycin, followed by filtering through
a 100-μm cell strainer [25, 28]. Following cell isolation,
FCCs were prepared for direct seeding into collagen
gels with passaged MSCs. Prior to mixing cells into 3D
constructs, MSCs were labeled using CellTrace Green
CFSE (Invitrogen, Grand Island, NY, USA; C34554)
and FCCs were labeled with CellTrace FarRed DDAO-SE
(Invitrogen; C34553). Cell media cocktails were mixed at
MSC:FCC ratios of 0:100, 25:75, 50:50, 75:25, and 100:0.
Since no live animals were used in this study, no IACUC
approval was required.
Construct generation
Collagen type I was extracted from Sprague–Dawley rat
tails (Pel-Freez Biologicals, Rogers, AZ, USA) and recon-
stituted in 0.1 % acetic acid at 30 mg/mL concentration
as previously described [25, 29, 30]. Briefly, the stock
collagen solution was mixed with working solutions of
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1N NaOH, 10× phosphate-buffered saline (PBS), and 1×
PBS to return the collagen to a neutral 7.0 pH and
300 mOsm and begin the gelation process [30]. Cell-
media cocktails were homogeneously mixed at a final
concentration of 25 × 106 cells/mL to form a collagen so-
lution at 20 mg/mL [25]. Collagen solution was gelled
between two glass plates to create a sheet gel 2 mm
thick, and molds were allowed to gel for 30 minutes at
37 °C. From each 2-mm thick gel, 30 8-mm diameter
samples were obtained using biopsy punches. Ten sam-
ples were used per time point at 1, 8, and 15 days (two
to confocal/histology, four to mechanical, and four to
biochemical analysis). Samples were cultured in media
containing DMEM, 10 % FBS, 100 μg/mL penicillin,
100 μg/mL streptomycin, 0.1 mM non-essential amino
acids, 50 μg/mL ascorbate, and 0.4 mM L-proline [25].
Culture media was collected and replenished every 3–4
days. Images of each sample were obtained at each
media change. Images were imported into ImageJ to cal-
culate the area of each construct. Cells and constructs
were cultured at 37 °C and 5 % CO2.
Cell shape analysis
At the desired time points, two samples from each ex-
perimental group were fixed in 10 % buffered formalin
for 48 hours and stored in 70 % ethanol. Fluorescence
imaging was performed on a Zeiss 710 confocal micro-
scope with a Zeiss Axio Observer Z1 inverted stand
using a 40×/1.2 C-Apochromat water immersion object-
ive. Images of MSCs labeled with CellTrace Green CFSE
and FCCs labeled with CellTrace FarRed DDAO-SE were
obtained separately for analysis. Four images and two
z-stacks per sample were taken, with at least ten cells
per image. Z-stacks were converted into a 2D pro-
jected image. Aspect ratio (AR) and cell area were
calculated using “area” and “centroid fit” (AR =major
axis/minor axis) in ImageJ software (National Institute
of Health) [31].
Biochemical content
Samples were collected and weighed to obtain a wet
weight (WW), then frozen, lyophilized, and weighed
again to obtain dry weight. As previously described,
DNA, glycosaminoglycan (GAG), and collagen content
were measured via the Hoechst DNA assay [32], a modi-
fied 1,9-dimethylmethylene blue (DMMB) assay at
pH 1.5 [33], and a hydroxyproline (hypro) assay, respect-
ively [34]. Biochemical contents were normalized to
DNA to account for construct contraction and cell pro-
liferation. Biochemical tests were analyzed on both con-
struct samples and media samples collected throughout
culture. Total content was calculated as a sum of bio-
chemical content in media added to total biochemical
content in the construct. Retention was calculated as a
percentage of content in construct relative to total
content.
Histology
Following fluorescent imaging, samples were dehydrated,
embedded into paraffin blocks, sectioned, and stained.
Picrosirious red staining was imaged using brightfield
microscopy and collagen fiber organization was visual-
ized under polarized light [25]. Immunohistochemistry
was conducted as previously described to further investi-
gate collagen content using antibodies for collagen type
I (Abcam, Cambridge, MA, USA; 34710), collagen type
II (Chondrex, Redmond, WA, USA; 7005), and collagen
type X (Abcam; 58632) [35]. Primary and secondary
antibody controls were run in parallel with samples for
immunohistochemistry stains (Additional file 2). Control
samples and experimental samples were stained in
the same batch process and exposed to the same
duration and concentration of reagents. Images were
obtained with a SPOT RT camera (Diagnostic Instru-
ments, Steriling Heights, MI, USA) attached to a
Nikon Eclipse TE2000-S microscope (Nikon Instru-
ments, Melville, NY, USA).
Mechanical properties
Four samples per experimental group were cut into 4-
mm diameter plugs and tested for compressive proper-
ties [36–38]. Samples (2-mm thick) were tested in con-
fined compression via a stress relaxation test performed
by imposing 10 × 100 μm steps (relaxation = 12 minutes,
strain = 5–45 %, steps = 5 %, n = 4). The resulting load
was then fit to a poroelastic model using a custom
MATLAB program to determine aggregate modulus
(HA) and hydraulic permeability (k). Mechanical testing
was performed on an Enduratec ElectroForce 3200 System
(Bose, Eden Prairie, MN, USA) using a 1-kg load cell.
Statistics
Biochemical data were analyzed by two-way analysis
of variance using Tukey’s t-test for post-hoc analysis
(SigmaPlot, San Jose, CA, USA). An equal probability
averaging method was used for GAG retention calcula-
tions to pair media samples with construct samples [39].
All data are expressed as mean ± standard deviation and
significance was determined with p < 0.05.
Results
Characterization of cell morphology
Cells embedded in collagen gels visualized using fluores-
cent probes showed that cells were homogeneously dis-
tributed within the construct, with limited direct cell–cell
contact. Within each construct, cells were homogenously
mixed between the two cell types, with FCCs and MSCs
distributed throughout the construct (Fig. 1a).
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MSCs had an increased projected area relative to
FCCs, with MSCs (mono-culture area = 169 ± 119 μm2)
approximately two-times the size of FCCs (mono-culture
area = 75 ± 40 μm2) at day 1. FCCs became smaller in
area after 8 days (mono-culture area = 42 ± 13 μm2) but
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Fig. 1 Cell shape and size images with analysis with all ratios presented as MSC:FCC. a Fluorescent images of biopsy constructs (red= FCC, green=MSC);
scale bar = 50 μm, n = 2. b Cell area calculations and c aspect ratio calculations (dotted line represents FCC population in co-culture and solid line
represents MSC cell population in co-culture). *p < 0.05, versus 100 % FCC; n = 4. AR Aspect ratio, FCC fibrochondrocyte, MSC mesenchymal
stem cell
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area = 45 ± 18 μm2). After 15 days in culture, MSCs had
reduced in size (mono-culture area = 162 ± 90 μm2);
however, they were still significantly larger than the FCC
cell population (Fig. 1b).
MSCs and FCCs exhibited distinct cell morphologies
at day 1 that became more homogeneous after 15 days
of culture (Fig. 1). FCCs appeared more rounded (mono-
culture AR = 1.4 ± 0.3) and MSCs appeared more elon-
gated (mono-culture AR = 2.0 ± 1.2) at day 1 (Fig. 1c).
MSC cell shape at day 1 was a mixture of circular and
elongated cell morphologies. After 15 days in culture,
both FCCs (mono-culture AR = 1.5 ± 0.4) and MSCs
(mono-culture AR = 1.7 ± 0.6) displayed a circular
morphology (Fig. 1a). FCC AR remained consistent be-
tween experimental groups in co-culture and throughout
the duration of co-culture with no statistical differences.
MSCs showed variable morphologies at 1 and 8 days,
and appeared to converge on the circular phenotype
after 15 days (Fig. 1a and c).
Matrix synthesis
Phenotypic changes were observed in MSC-laden gels as
measured through changes in matrix content over time.
Gels contained essentially no GAG at the beginning of
culture. After fifteen days, GAG normalized to DNA
content increased to 1.08 ± 0.3 μg/μg in FCC mono-
culture and to 1.91 ± 0.16 μg/μg in MSC mono-culture.
GAG/DNA content increased linearly with MSC con-
tent at fifteen days (R2 = 0.94) and all groups had a
significant increase in GAG/DNA content with time
(Fig. 2a; p < 0.001). GAG content in media was recorded
in order to observe if cells were producing GAGs that
were being lost into the cell media. The increasing
GAG/DNA content increasing with MSC content remained
consistent when GAG in media is combined with GAG in
the construct (Fig. 2b). Interestingly, 50:50 co-culture
retained the greatest amount of GAG within the construct
(73 ± 3 %), significantly higher than both FCC and MSC
mono-culture. MSC gels at 50:50, 75:25, and 100:0 all
retained significantly higher amounts of GAG (73 ± 3 %,
70 ± 2 %, and 63 ± 2 %, respectively) compared to FCC
mono-culture (52 ± 7 %; Fig. 2c). Hydroxyproline was
measured as an indication of collagen content. All gels
contained collagen at 1 day since the gels were comprised
of collagen type I; however, over time the cells break down
their collagen matrix. FCCs displayed a more catabolic re-
sponse than the MSCs as the MSC mono-culture group
had no significant changes in hypro/DNA (Fig. 2d).
Hydroxyproline content measured in the media and con-
struct together indicated that the total collagen in the sys-
tem is not changing with time (Fig. 2e). Similar to GAG
retention, hydroxyproline retention in the constructs was
greatest in the 50:50 co-culture group (77 ± 3 %; Fig. 2f).
Collagen constructs contracted over time, but maintained a
cylindrical shape (Additional file 3A). MSC-containing
constructs contracted between 40–60 % of their original
size by day 15, while FCC mono-culture gels contracted




















































































































































































Fig. 2 Biochemical analysis with all ratios presented as MSC:FCC. a Glycosaminoglycan (GAG) content in construct normalized to DNA content.
b Total GAG produced by sample calculated as a sum of GAG in the media and GAG in the construct. c GAG retained within construct calculated
as a percentage of content in samples to total content in samples and media over time. d Hydroxyproline (hypro) content in construct normalized to
DNA content. e Total hypro produced by sample calculated as a sum of GAG in the media and GAG in the construct. f Hypro retained within construct
calculated as a percentage of content in samples to total content in samples and media over time. *p < 0.05, versus 100 % (0:100) FCC within time
point; n = 4. FCC Fibrochondrocyte, MSC mesenchymal stem cell
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There was no significant difference between gels; there-
fore, contraction does not play a role in biochemical
differences between these groups. Cells in constructs pro-
liferated between days 1, 8, and 15, indicating a healthy
cell population. DNA content between groups at day 1
showed no significant differences; however, co-culture and
MSC mono-culture groups had greater proliferation than
FCC mono-culture over time (Additional file 3C). GAG
and hydroxyproline content were normalized to DNA to
account for cellular proliferation with time.
Histological staining and immunochemistry revealed
matrix presence and localization. All experimental
groups showed the presence of collagen with small dis-
organized fibers forming in the body of the constructs.
Small clumps of fibers formed throughout the construct
with some increased alignment occurring near the edges
(Fig. 3, rows 1 and 2). Immunohistochemistry was used
to probe for specific types of collagen in the constructs.
All groups stained positive for collagen type I and II
after 15 days (Fig. 3, rows 3 and 4). No staining for colla-
gen type II was observed in day 1 samples; thus, positive
staining for collagen type II at 15 days was produced
during culture (Additional file 4). After 2 weeks of cul-
ture, MSC mono-culture gels showed positive staining
for collagen type X compared to other culture groups
(Fig. 3, row 5).
Mechanical characterization
Mechanical properties of samples improved with MSC
cellular content and time in culture (HA values, p < 0.05).
Aggregate modulus of 50:50 co-culture (31 ± 2 kPa) was
significantly higher that FCC mono-culture after 15 days.
FCCs had the lowest aggregate modulus after 15 days in
culture (21 ± 1 kPa) (Fig. 4a). Permeability reflected a simi-
lar trend to aggregate modulus with permeability decreas-
ing from day 1 in culture; however, there was no statistical
difference between sample groups at 15 days (Fig. 4b).
Discussion
The objective of this study was to examine MSC pheno-
type when co-cultured with FCCs with the overarching
goal to examine regenerative potential of MSCs for me-
niscus repair. We hypothesized that co-culture of MSCs
with FCCs in a 3D collagen scaffold would facilitate in-
creased matrix accumulation and mechanical properties.
In this study, MSCs mono-cultured and co-cultured with
FCCs displayed a phenotypic change related to cell
morphology and matrix production. MSCs transition to
a chondrogenic morphology and outperform FCCs in
GAG production after 15 days of culture. Despite the
advantageous matrix synthesis of MSCs, they had a
hypertrophic tendency that was mitigated by co-culture.
These data show that MSCs in co-culture with meniscal
Fig. 3 Histological staining of samples after 15 days of culture with all ratios presented as MSC:FCC. Picrosirius red staining imaged with
brightfield microscopy (row 1) and polarized light (row 2). Immunohistochemical staining of collagen type I (row 3), collagen type II (row 4), and
collagen type X (row 5). Counterstained with hematoxylin; scale bars = 200 μm. Col, Collagen, FCC fibrochondrocyte, MSC mesenchymal stem cell
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FCCs present specific advantages for meniscus tissue en-
gineering, specifically increasing GAG retention in the
construct, decreasing MSC hypertrophy, and improving
mechanical properties.
Cell aspect ratio is well established as a measure of cell
morphology and cell phenotype; however, this is the first
study to examine changes in MSC morphology in co-
culture with FCCs. In this study, MSCs underwent a dis-
tinct change in cell morphology between 1, 8, and
15 days. FCCs exhibited a consistent circular morph-
ology, while MSCs started with an elongated morph-
ology that transitioned to a circular morphology over
time. Cell shape is directly linked to cell phenotype and
has been shown to be dictated by the surrounding
mechanical and chemical environment [40–42]. Reduc-
tion in cell spreading and/or transition to circular
phenotype is associated with mesenchymal chondrogen-
esis. Previous work has shown that prevention of cell
spreading, through disruption of the cytoskeleton using
cytochalasin, increased chondrogenesis [43]. Pellet cul-
tures are hypothesized to aid in MSC chondrogenesis by
providing a 3D environment that forces cells into a com-
pacted shape, reducing cell spreading [18]. In this study,
cultured MSCs, even in a material that supports adhe-
sion and spreading, moved to a rounded phenotype and
produced proteoglycans.
Consistent with other studies, we found that MSCs in-
creased collagen type X expression in mono-culture and
that this response was mitigated in co-culture. These
MSCs originate from bone marrow and are known to
have similar functional behavior to growth plate chon-
drocytes which express the hypertrophic phenotype [44].
Co-culture has been shown in multiple studies to miti-
gate hypertrophic effects both with chondrocytes [22,
24, 26] and, to a lesser extent, with fibrochondrocytes
[20, 21]. Previous studies focused on evaluating collagen
type X gene expression as a marker of hypertrophy,
whereas we measured collagen type X presence in
constructs using immunohistochemistry. Hypertrophy is
also characterized by an enlargement of cell area and
volume. In this study we measure cell area and observed
that MSCs were nearly twice the size of FCCs, but there
was no significant enlargement of cells with time in cul-
ture. Although not significant, the MSC fraction of cells
in co-culture groups showed a reduction in area after
15 days, while MSCs in mono-culture showed a slight
increase in area, indicating a more hypertrophic cell
population in MSC mono-culture [45]. This study sup-
ports the body of work that suggests that co-culture of
MSCs with chondrocytes or FCCs is a mechanism for
functional inhibition of MSC hypertrophy.
Cell–material interactions are known to influence
changes in cellular behavior and phenotype. Collagen
was the primary scaffold material in our gels, which is
known to influence cell phenotype through both chem-
ical and mechanical pathways. Similar to previous pellet
culture studies of MSC and FCC mono- and co-culture
[20, 21], GAG and collagen type II were increased in all
culture groups in meniscal media. The FCC mono-
culture gel in this study appeared to have an increased
collagen type I expression compared to gels with MSCs.
The meniscus is composed primarily of collagen type I,
with collagen type II being the second most prominent
collagen, especially in the cartilaginous inner region
[46, 47]. The MSC containing groups did produce more
GAG in construct which is consistent with a more chon-
drogenic behavior and less collagen type I production seen
in the inner zone of the meniscus [48]. In this study, the
MSC mono-culture group produced the most GAG, in
contrast to other studies in which MSC mono-cultures
usually contain the lowest GAG concentration [20, 21, 26,
49]. This discrepancy is likely due to cell–material interac-
tions which provide a physical diffusion barrier that is
lacking in pellet culture. Previous studies using alginate
showed that MSCs produced more GAG in mono-culture
than FCCs, but were unable to retain GAG within the
construct [50]. Another study showed that MSCs cultured
on a collagen scaffold had increased expression of collagen
type II, sox9, and aggrecan expression compared to algin-
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Fig. 4 Mechanical analysis with all ratios presented as MSC:FCC. a Aggregate modulus and (b) permeability of constructs. *p < 0.05, versus 100 %
FCC; n = 3–4. FCC Fibrochondrocyte, MSC mesenchymal stem cell
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articular chondrocytes co-cultured with MSCs in pellet
culture versus within a collagen type I scaffold demon-
strated that GAG/WW content was lowest in FCC mono-
culture group in collagen, whereas in pellet culture the
FCC group contained the greatest amount on GAG/DNA
[52]. This study is the first to examine MSC and FCC co-
culture in a collagen gel and supports that the matrix used
to culture MSCs is an important contributor to guiding
MSC phenotype.
Previous studies attribute phenotypic changes to close
cellular proximity in pellet cultures; however, our study
demonstrated that direct cell–cell contact is not neces-
sary for phenotypic changes in MSC behavior. Studies in
pellet culture have noted increased matrix expression in
co-cultures compared to mono-culture controls, which
could be attributed to direct cell–cell contact resulting
in an interaction effect [20, 21]. Furthermore, pellet cul-
ture may promote chondrogenesis because cells are
forced into a compact circular phenotype rather than
allowing them to spread on a surface [18]. Previous
studies have shown that stem cell differentiation can be
controlled by soluble signaling factors [18, 48, 53]. Spe-
cifically, conditioned media from chondrocytes directed
chondrogenic differentiation of MSCs and enhanced
matrix production [54, 55]. A modeling study concluded
that a single cell can effectively communicate within a
domain of 250 μm [56]. Another study demonstrated
that soluble effects require close proximity because in-
creased matrix and mechanical properties were only
seen in co-cultured MSC and chondrocyte hydrogels as
opposed to two distinct hydrogels cultured in the same
well [24]. In this study, there was increased matrix ex-
pression of GAG and collagen type I in constructs. Of
particular interest was that the 50:50 culture group had
the highest GAG retention. Previously, we have shown
that MSCs in mono-culture are deficient in link protein
compared to chondrocyte cells which resulted in a loss
of GAG into media in MSC constructs [50]. Our co-
cultured groups likely had the advantage of FCC produc-
tion of link protein to retain the increased production of
GAG from MSCs. This study supports that MSC pheno-
typic changes do not require direct cell–cell contact,
suggesting that soluble signaling factors play a key role
in directing phenotypic changes.
This study was the first to show mechanical evaluation
of constructs using FCC and MSC co-culture. Conducting
these studies in a 3D scaffold enabled the measurement of
mechanical properties to quantify effects that cellular re-
modeling and matrix production had on mechanical prop-
erties. MSCs and FCCs cultured in collagen gels stiffened
with time in all groups. The 50:50 co-culture showed the
greatest increase in compressive properties, with 100:0
MSC mono-cultures showing a similar increase. The
100:0 MSC mono-culture had the greatest GAG/DNA
production; however, 50:50 co-culture had the greatest
GAG retention. Previously we have shown that compres-
sive mechanical properties are not exclusively correlated
with GAG content and that collagen content is particu-
larly important for the compressive properties of meniscal
constructs [25, 28]. Furthermore, the mechanical proper-
ties of a substrate are a key factor contributing to MSC
fate [40, 57]. Increasing construct stiffness in a 3D gel
likely contributed to phenotypic changes in gels toward
chondrogenic morphology and matrix expression.
This study has some limitations. The stem cells used
in this study were not tested and sorted for cell surface
antigens and are therefore a heterogeneous population.
However, MSCs used in this study were characterized
and validated by two well-established defining criteria:
plastic adherence and trilineage differentiation. The
protocol used in this study has been well established in
previous literature to yield viable stem cells [26]. Bovine
MSCs and FCCs were used for the purposes of these ex-
periments. The use of bovines as a cell source could
affect clinical translatability of experiments. The 50:50
co-culture showed the best mechanical properties and
GAG retention; however, obtaining 50 % FCCs may not
be clinically feasible.
Conclusion
This study shows that MSC phenotype can be influenced
by co-culture in a 3D dimensional construct. MSCs dem-
onstrated a transition to chondrogenic phenotype sup-
ported by changes in cell shape, matrix production, and
mechanical properties. Maximal mechanical performance
and GAG retention was observed in the 50:50 co-culture
group. Additionally, co-culture groups showed reduced
hypertrophy to MSCs in mono-culture. While the specific
cause of MSC differentiation remains unknown, this study
validates that MSCs in 3D scaffold co-culture transition to
FCC phenotype, demonstrating their applicability for 3D
tissue-engineered menisci as well as other tissue engineer-
ing applications.
Additional files
Additional file 1: Trilineage differentiation of bone marrow derived
MSCs. Control samples cultured in growth medium and stained with
Alizarin Red S, Oil Red O or Safranin O. Samples cultured in osteogenic
media stained with Alizarin Red, samples cultured in adpogenic media
stained with Oil Red O and samples cultured in chondrogenic media
stained with Safranin O. (PPTX 120 kb)
Additional file 2: Immunohistochemicial staining controls for collagen
type I, II, X. Primary antibody controls run for all groups (−). Extensor
tendon section from bovine knee as positive control for collagen type I.
Articular cartilage transverse section from bovine distal femur as positive
control for collagen type II. Growth plate from bovine distal femur as
positive control for collagen type X. Counterstained with hematoxylin;
scale bar on 0 week collagen gel = 200 μm on 100× objective; all other
scale bars = 500 μm on 40× objective). (PPTX 3053 kb)
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Additional file 3: (A) Macroscopic images of constructs taken at each
time point and condition. (B) Projected area calculations of samples over
time. (C) DNA content normalized to wet weight of samples. *p < 0.05,
versus 100 % FCC; n = 4. (PPTX 513 kb)
Additional file 4: Immunohistochemicial staining for collagen type II.
Counterstained with hematoxylin; scale bar = 200 μm. (PPTX 1035 kb)
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